Span Divergent P/B Ratio
Span Divergent (SDL) P/B ratio is -6.32 (Low), book value per share ₹-15.00 vs Healthcare average P/B of -0.79 — Very Low - Significant discount to book value, potential distress or value opportunity. View SDL 52-week performance for the annual high/low range and current price position.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
SDL P/B Ratio — Valuation Insights & Book Value Analysis
Span Divergent price-to-book ratio interpretation, valuation status and historical context — current P/B -6.32 (Low). Compare with SDL DCF valuation to assess whether the stock is under or overvalued.
- Stock appears undervalued with PB of -6.32, trading below book value
- Trading below book value - potential value opportunity or financial distress signal
- Current PB is 568.1% below historical average
- Trading at discount to sector average PB of -0.79
Span Divergent P/B Ratio Historical Trend
SDL annual price-to-book ratio — 1 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see SDL share price.
SDL Historical P/B Ratio — Book Value Per Share & Year-End Price
Span Divergent annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2021 | 1.35 | ₹11.67 | ₹15.75 | ₹7 | Moderate |
SDL vs Healthcare Peers — P/B Ratio Comparison
Span Divergent P/B -6.32 vs Healthcare average -0.79, median 0.61 — range -31.21–1.04.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -31.21 | ₹25 | Low |
| Sun Pharma Advanced Rese… | SPARC | -16.05 | ₹5,310 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.31 | ₹75 | Low |
| Parmax Pharma | PARMAX | -2.16 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.76 | ₹121 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.63 | ₹55 | Low |